Search Within

Gunjan Lalitchandra Shah

  1. "DigITs Research Group"
Formats
  1. Meeting Abstract (63)
  2. Journal Article (26)
  3. Research Letter (4)
Groups
  1. Bone Marrow Transplant (93)
  2. Center for Hematologic Malignancies (93)
  3. Department of Medicine (93)
  4. DigITs Research Group (93)
  5. Hematologic Malignancies, Division of (93)
  6. Survivorship Research (93)

More Groups

People
  1. Molly Maloy (90)
  2. Sergio Giralt (83)
  3. Miguel-Angel Perales (76)
  4. Sean Devlin (73)
  5. Michael Scordo (67)
  6. Parastoo Dahi (47)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (8)
  5. 2020 (24)
  6. 2019 (18)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (45)
  2. Blood (18)
  3. Bone Marrow Transplantation (11)
  4. Blood Advances (6)
  5. Leukemia and Lymphoma (3)
  6. Haematologica (2)

More Publications

Publishers
  1. Elsevier Inc. (48)
  2. American Society of Hematology (24)
  3. Nature Publishing Group (13)
  4. Taylor & Francis Group (3)
  5. Ferrata Storti Foundation (2)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (93)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation
    Journal Article

    Melica, G.; Preston, E.; Palazzo, M.; Seier, K.; Malard, F.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Maslak, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient reported outcomes using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy
    Meeting Abstract

    Shah, G. L.; Lobaugh, S.; Sukhu, R.; Devlin, S. M.; Atkinson, T.; Kemeny, E.; Stetson, P.; Perales, M. A.; Giralt, S. A.; Scordo, M.
    Blood (2023)

    Fulltext@MSK | Save
  • Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients
    Journal Article

    Laracy, J. C.; Yan, J.; Steiger, S. N.; Tan, C. A.; Cohen, N.; Robilotti, E. V.; Fender, J.; Cohen, S.; Korde, N.; Lee-Teh, M.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Adintori, P. A.; Knezevic, A.; Devlin, S. M.; Buchan, M. L.; Preston, E. V.; Lin, A. P.; Rodriguez, N. T.; Carino, C. A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma
    Journal Article

    Dahi, P. B.; Lee, J.; Devlin, S. M.; Ruiz, J.; Maloy, M.; Rondon-Clavo, C.; Petrlik, E.; Tamari, R.; Shah, G.; Scordo, M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • The International Prognostic Index is associated with outcomes in diffuse large B cell lymphoma after chimeric antigen receptor T cell therapy
    Journal Article

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Shouval, R.; Afuye, A. O.; Silverberg, M. L.; Batlevi, C. W.; Dahi, P.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save